{"id":579379,"date":"2010-05-26T09:05:58","date_gmt":"2010-05-26T13:05:58","guid":{"rendered":"http:\/\/www.xconomy.com\/?p=81807"},"modified":"2010-05-26T09:05:58","modified_gmt":"2010-05-26T13:05:58","slug":"anadys-raises-12-5m-hires-banker","status":"publish","type":"post","link":"https:\/\/mereja.media\/index\/579379","title":{"rendered":"Anadys Raises $12.5M, Hires Banker"},"content":{"rendered":"\n
Biotech<\/a>, Finances<\/a>, Hepatitis C<\/a><\/div>\n

\t\tLuke Timmerman wrote:<\/strong><\/p>\n

Anadys Pharmaceuticals (NASDAQ: ANDS<\/a>), the San Diego-based developer of a treatment for hepatitis C, said today<\/a> it has raised $12.5 million through a registered stock offering with certain institutional investors. The company has agreed to sell about 5.8 million shares at $2.15 apiece, about a 3.5 percent discount from yesterday’s closing stock price of $2.23. Lazard Capital Markets served as the lead placement agent in the offering. Separately, Anadys said<\/a> today it has hired Lazard as a strategic adviser as it “pursues various avenues aimed at value recognition for its stockholders,” according to a statement. Anadys burned through about $5 million of its cash reserves in the first quarter, and was left with about $15 million left in the bank at the end of March.<\/p>\n

Comments<\/a> | Reprints<\/a> | Share:  
\n\"Retweet\"\/<\/a>
\n \"Facebook\"\/<\/a>
\n \"Email\"\/<\/a>
\n \"Share\"\/<\/a>\n<\/div>\n

\t \t\t\t
\n\t\t\t\t\t\t
\n\t\t\t
\n\t\t\t<\/a>
\n\t\t\t
\n\t\t\t\t

\n

\n\"\"<\/a>
\n\"\"\"\"<\/p>\n

<\/img><\/a>
\n<\/img><\/a><\/p>\n

<\/p>\n","protected":false},"excerpt":{"rendered":"

Biotech, Finances, Hepatitis C Luke Timmerman wrote: Anadys Pharmaceuticals (NASDAQ: ANDS), the San Diego-based developer of a treatment for hepatitis C, said today it has raised $12.5 million through a registered stock offering with certain institutional investors. The company has agreed to sell about 5.8 million shares at $2.15 apiece, about a 3.5 percent discount […]<\/p>\n","protected":false},"author":1192,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[7],"tags":[],"class_list":["post-579379","post","type-post","status-publish","format-standard","hentry","category-news"],"_links":{"self":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts\/579379","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/users\/1192"}],"replies":[{"embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/comments?post=579379"}],"version-history":[{"count":0,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts\/579379\/revisions"}],"wp:attachment":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/media?parent=579379"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/categories?post=579379"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/tags?post=579379"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}